Laura Simon Treml
Corporate Officer/Principal presso ARATANA THERAPEUTICS INC
Posizioni attive di Laura Simon Treml
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26/03/2013 | - |
Storia della carriera di Laura Simon Treml
Formazione di Laura Simon Treml
University of Pennsylvania | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Borsa valori
- Insiders
- Laura Simon Treml
- Esperienza